All In Biotech

Free tool

FAERS Monitor: Flovent Diskus 250

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020833 or its brand name (Flovent Diskus 250, Fluticasone Propionate). Reports on generic versions are filed under their own applications.

Reports

30,966

Serious

17,995

58% of reports

Hospitalization

8,091

Death reported

1,765

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea2,500
  • drug ineffective2,452
  • headache2,353
  • fatigue2,173
  • off label use1,942
  • pain1,915
  • nausea1,881
  • cough1,807
  • asthma1,684
  • diarrhoea1,667
  • product dose omission issue1,518
  • pneumonia1,477
  • dizziness1,436
  • malaise1,275
  • vomiting1,240

Reports by year received

View as table
YearReports
2004383
2005329
2006341
2007414
2008430
2009383
2010584
2011918
20121,016
2013372
2014484
20151,120
20161,530
20171,239
20181,698
20191,718
20202,072
20211,883
20222,236
20232,733
20243,322
20253,319
20262,441

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,023,193 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
asthmaSignal1,68410.39.813,928
coughSignal1,8074.44.24,775
product dose omission issueSignal1,5183.53.42,760
pneumoniaSignal1,4773.13.02,133
dyspnoeaSignal2,5003.02.93,428
headacheSignal2,3532.62.52,285
painSignal1,9152.12.01,164
malaise1,2752.01.9626
dizziness1,4362.01.9687
fatigue2,1731.91.8956
vomiting1,2401.81.7443
diarrhoea1,6671.81.7558
nausea1,8811.61.5457
off label use1,9421.51.4345
drug ineffective2,4521.31.2144

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.